Advertisement

Therapeutic Value of Drugs Lower for Supplemental Versus First Indications

0

For first three approved indications, second and third indication approvals less likely to have high value rating

CDC: More Than Three-Quarters of Americans 16 and Older Have Been Infected With COVID-19

0

Federal figures have made it clear how much the virus spread undetected or unreported

Long-Acting ART Achieves Virologic Suppression for People With HIV

0

97.5 percent were projected to achieve virologic suppression by a median of 33 weeks

Lower Extremities Have Highest Surgical Site Infection Rates With Mohs Surgery

0

Findings especially for flap and graft closures

Treatment Failure Down With Standard-Course Therapy in Pediatric UTI

0

Children receiving short-course therapy also had increased likelihood of asymptomatic bacteriuria or positive urine culture at follow-up

Incidence of Foodborne Pathogens Back to Prepandemic Levels

0

Annual incidences of illnesses caused by Campylobacter, Salmonella, Shigella, and Listeria during 2022 similar to those during 2016 to 2018

Mosquitoes Test Positive for Malaria in Florida

0

The testing follows discovery of four locally acquired cases of malaria in Florida and one in Texas -- the first known since 2003

Compliance With CMS Price Transparency Rule Improved With Penalty Increases

0

$500,000 increase in penalty linked to a 2.9 percentage point increase in compliance

Bulevirtide Linked to Decline in Hepatitis D Virus RNA Levels

0

Normalization of alanine aminotransferase also seen with bulevirtide 2- or 10-mg

Pegozafermin Leads to Improvements in Fibrosis in NASH

0

Improvements also seen in NASH resolution with pegozafermin 15 or 30 mg weekly, or 44 mg every two weeks